Sector consensus Scholar Rock Holding Corporation
Stocks
SRRK
US80706P1030
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.03 USD | -0.94% |
|
+6.04% | +27.20% |
| 07-07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 06-11 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 59.31 | +5.86% | 16 | ||||||
| 886.67 | +10.86% | 15 | ||||||
| 146.67 | +27.1% | 17 | ||||||
| 197.05 | +69.1% | 21 | ||||||
| 106.64 | +30.3% | 20 | ||||||
| 40.53 | +31.14% | 22 | ||||||
| 2,334.74 | +23.4% | 15 | ||||||
| 1,049.67 | -23.9% | 7 | ||||||
| 547.64 | +14.23% | 17 | ||||||
| 50.38 | -10.22% | 16 | ||||||
| 678.71 | +20.04% | 14 | ||||||
| 21.41 | +80.86% | 13 | ||||||
| 90.64 | +5.71% | 11 | ||||||
| 107.8 | +27% | 20 | ||||||
| 148.81 | +77.94% | 20 | ||||||
| 125.12 | +1.07% | 16 | ||||||
| 13 | +47.73% | 3 | ||||||
| 99.01 | +37.69% | 14 | ||||||
| 82.5 | -1.19% | 10 | ||||||
| 109 | +85.66% | 9 | ||||||
| Average | 344.77 | +28.02% | 15 | ||||||
| Weighted average by Cap. | 432.38 | +26.03% | 16 |
- Stock Market
- Stocks
- SRRK Stock
- Sector Scholar Rock Holding Corporation
- Sector consensus
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
